Lactase Enzyme Market: Customer-centric Approach Drives Innovation Developing Lactase-measuring De

Published: Tue Sep 10 2019

Well-established manufacturers of lactase enzymes, with their occupancy largely concentrated in Europe, are eyeing consolidation in emerging markets to strengthen their global market foothold. These manufacturers are now targeting untapped opportunities in the developing nations. Leading players such as Koninklijke DSM N.V. are witnessing significant business expansion related to dietary supplements, which is a key application area of lactase enzyme, in China. Additionally, other key players, such as Chr. Hansen Holding A/S, are focusing on reducing their dependency on European market, shifting their focus to countries in Latin America and Middle East & Africa.

For further insights on the global Market, read the Report Summary:

The significant rise in global demand for lactose-free food products is widening the range of food & beverage applications of lactase enzymes, which is influencing business strategies of market players in the lactase enzyme market. An upsurge in demand for lactase enzymes in the F&B space is encouraging manufacturers, such as Chr. Hansen A/S, in putting efforts to achieve consumer-driven commercial success in the lactase enzyme market. Sensing evolving requirements of end-users to ensure low lactose levels in dairy products, prominent lactase enzyme manufacturers such as Chr. Hansen A/S, have introduced novel test kits that measure lactose levels. Such product launches by leading market players are aimed at attracting dairy manufacturers who continuously seek ideal solutions for process control. Key lactase enzyme manufacturers are also entering into strategic collaborations for marketing their cost-effective lactose-analyzing devices, which enable efficient and fast measurement of lactose levels in dairy products.

Lactase enzymes continue to witness widespread adoption across various application areas ranging from food & beverages to pharmaceuticals. However, challenges prevail apropos of lactase enzymes’ stability when subjected to thermal and mechanical treatment, which in turn have adverse impact on efficiency of the industrial processes. These challenges are being significantly resolved by manufacturers, who are adopting advanced production technologies such as immobilization and genetic engineering, which ensure higher stability and improved productivity. Benefits of genetic engineering that include high-quality yield and accelerated manufacturing process of lactase enzymes, and suitability of immobilization technology when it comes to efficient, large-scale manufacturing of lactase enzymes have meant that, these production technologies will remain preferred among lactase enzyme manufacturers.

To gain further interesting insights on the facets of the market at a regional or global level, request for the Sample Report at:

Lactose intolerance continues to persist as a major concern among the world’s adult population, with nearly 75% unable to consume milk and its derivatives. The advent of lactase enzyme, such as β-galactosidase, has emerged as a boon for dairy producers, as it hydrolyzes lactose to readily digestible sugars such as galactose and glucose. The recent surge in number of consumers shifting towards lactose-free dairy products is making a huge impact on the dynamics of the lactase enzyme market. Lactose-free dairy products are gaining popularity, not only among lactose-intolerant consumers, but along among consumers who can digest lactose, which reflects a broader consumer trend. Dairy manufacturers are capitalizing on the rising retail value of lactose-free dairy products as compared to that of regular dairy products.

This is encouraging most dairy manufacturers worldwide to add lactase enzymes in the dairy production processes, which is boosting demand for lactase enzymes across the world. Leading manufacturers in the lactase enzyme market are adopting strategies to leverage rising demand for lactose-free dairy products by increasing production of lactase enzymes. For example, DuPont de Nemours and Company " an American conglomerate " recently announced that, with its GODO-YNL2 lactase enzyme, the company is aiming to boost profitable growth in the dairy industry. Chr. Hansen Holding A/S " another leading manufacturer in the lactase enzyme market " declared its strategy to invest heavily in its dairy fermentation capacity in Copenhagen to benefit from the rapidly-growing dairy industry.

Request for the Report Customization:

About Us

Fact.MR’s methodology is robust and comprehensive. We employ a range of tools and assets to develop an all-encompassing coverage of a range of industries. We compile data points at local, country, regional, and global level " our approach to capturing the finest nuances, without losing sight of the bigger picture helps us in developing accurate and reliable forecasts and estimates.

Fact.MR has a standard set of guidelines and standards that help maintain a level of consistency across all of our research offerings. The standardization includes step-by-step documentation of the methodologies and guidelines on the sources that are to be used for incorporation of objective and accurate data.

The standardization also involves use of industry-wide analytical tools, and rigorous quality checks to validate market forecasts and sizes. Our unwavering focus on standardization ensures that clients receive the same quality of research and analysis that Fact.MR is known for.

Contact Us

Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Tel: +353-1-4434-232
Tel: +353-1-6111-593

Company: FACTMR
Contact Name: Aman
Contact Email: info@factmr.comm
Contact Phone: +353-1-4434-232

Visit website »